User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 9 results.
    • Journal article
    Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy
    Giles, F.J. Abruzzese, E. Rosti, G. Kim, D.-W. Bhatia, R. Bosly, André[UCL] Goldberg, S. Kam, G.L.S. Jagasia, M. Mendrek, W. Fischer, T. Facon, T. Dünzinger, U. Marin, D. Mueller, M.C. Shou, Y. Gallagher, N.J. Larson, R.A. Mahon, F.-X. Baccarani, M. Cortes, J. Kantarjian, H.M. (2010) Leukemia — Vol. 24, no.7, p. 1299-1301 (2010)
    • Journal article
    Cytogenetics in multiple myeloma: A multicenter study of 24 patients with t(11;14)(q13;q32) or its variant
    Lai, JL Michaux, Lucienne[UCL] Dastugue, N. Vasseur, F. Daudignon, A Facon, T. Bauters, F Zandecki, M (1998) Cancer Genetics and Cytogenetics — Vol. 104, no. 2, p. 133-138 (1998)
    • Journal article
    Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma
    Samani, KK Brazier, M Mathiot, C. Kamel, S Jamart, Jacques[UCL] Jaubert, J. Blanc, M. Azais, I. Facon, T. Leleu, X (2005) Annals of Hematology — Vol. 84, no. 1, p. 19-24 (2005)
    • Speech
    Bortezomib Plus Dexamethasone Versus Reduced-dose Bortezomib Plus Thalidomide-dexamethasone As Induction Prior To Autologous Transplantation in Newly Diagnosed Myeloma
    Harousseau, J. L. Avet-Loiseau, H. Mary, J. Facon, T. Attal, M. Doyen, Chantal[UCL] Hulin, C. Garderet, L. Tiab, M. Lepeu, G. Araujo, C. Caillot, D. Petillon, M. Mathiot, C. Moreau, P. (2010) 15th Annual Meeting of the European-Hematology-Association — Barcelona(Spain)
    • Speech
    Cytogenetics in multiple myeloma: A multicentre study of 24 patients with t(11;14) (q13;q32) or variant.
    Lai, JL Michaux, Lucienne[UCL] Dastugue, N. Daudignon, A Vasseur, F. Zandecki, M Bauters, F Facon, T. (1996) —
    • Speech
    Osteonecrosis of the Jaw in Multiple Myeloma Patients: Risk Factors of Early ONJ, Decreased Impact After 2005
    Fuzibet, J. G. Vekemans, Marie-Christiane[UCL] Rossignol, B. Vieillard, M. H. Fontas, E. Hulin, C. Garderet, L. Marevoet, M. Blanc, M. Azais, I. Marit, G. Facon, T. Moreau, P. (2009) —
    • Journal article
    Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS)
    Mathiot, C. Mary, JY. Tartour, E Facon, T. Monconduit, M. Grosbois, B. Pollet, JP Michaux, JL. Ziegler, LE Sautes, C Bataille, R. Fridman, WH (1996) British Journal of Haematology — Vol. 95, no. 4, p. 660-665 (1996)
    • Journal article
    Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
    Moreau, P. Attal, M. Garban, F. Hulin, C. Facon, T. Marit, G. Michallet, M. Doyen, Chantal[UCL] Leyvraz, S. Mohty, M. Wetterwald, M. Mathiot, C. Caillot, D. Berthou, C. Benboubker, L. Garderet, L. Chaleteix, C. Traullé, C. Fuzibet, J. G. Jaubert, J. Lamy, T. Casassus, P. Dib, M. Kolb, B. Dorvaux, V. Grosbois, B. Yakoub-Agha, I. Harousseau, J. L. Avet-Loiseau, H. SAKK IFM Group (2007) Leukemia — Vol. 21, no.9, p. 2020-2024 (2007)
    • Speech
    Prognostic evaluation in multiple myeloma: Impact of new prognostic factors including urinary bone resorption markers.
    Samani, KK Brazier, M Mathiot, C. Kamel, S Jamart, Jacques Facon, T. (2001) —